Home
/
Autolus Therapeutics plc
/
Financials
/
Quarterly
Autolus Therapeutics plc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Autolus Therapeutics plc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2025
Mar 31, 2025
$8.98M
May 8, 2025
Q1
2025
Mar 31, 2024
$10.09M
May 8, 2025
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$21.19M
Nov 12, 2025
Q2
2025
Jun 30, 2025
$20.92M
Aug 12, 2025
Q3
2025
Sep 30, 2024
$0
Nov 12, 2025
Q2
2025
Jun 30, 2024
$0
Aug 12, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($79.12M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($47.92M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($70.16M)
May 8, 2025
Q2
2025
Mar 31, 2025
($70.16M)
Aug 12, 2025
Q3
2025
Sep 30, 2024
($82.09M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($58.27M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($52.69M)
May 8, 2025
Q2
2025
Mar 31, 2024
($52.69M)
Aug 12, 2025
Q3
2024
Sep 30, 2023
($45.85M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($45.55M)
Aug 8, 2024
Q2
2024
Mar 31, 2023
($39.81M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($39.81M)
May 17, 2024
Q3
2023
Sep 30, 2022
($42.77M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($71.62M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($61.22M)
Aug 12, 2025
Q1
2025
Mar 31, 2025
($65.24M)
May 8, 2025
Q3
2025
Sep 30, 2024
($67.88M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($58.93M)
Aug 12, 2025
Q1
2025
Mar 31, 2024
($38.76M)
May 8, 2025
Q3
2024
Sep 30, 2023
($42.91M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($44.38M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($39.15M)
May 17, 2024
Q3
2023
Sep 30, 2022
($43.49M)
Nov 9, 2023